| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0921-4410(03)21032-2 |
| P698 | PubMed publication ID | 15338769 |
| P2093 | author name string | Hendrik van den Berg | |
| P2860 | cites work | EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma | Q27851507 |
| Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 | Q28245141 | ||
| Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy | Q28350866 | ||
| Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) | Q28366229 | ||
| High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance | Q28366242 | ||
| Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro | Q28369849 | ||
| Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome | Q29615538 | ||
| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
| Identification of the von Hippel-Lindau disease tumor suppressor gene | Q29618644 | ||
| Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21 | Q30338283 | ||
| Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881. | Q30587781 | ||
| Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor | Q31826551 | ||
| How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review | Q31826696 | ||
| Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study | Q32034383 | ||
| Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group | Q33182388 | ||
| Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study | Q33335538 | ||
| Isolated lower extremity chemotherapeutic infusion for treatment of osteosarcoma: experimental study and preliminary clinical report | Q33337595 | ||
| Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors. | Q33339811 | ||
| High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases | Q33340441 | ||
| Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma | Q74172973 | ||
| Parental occupational exposures to chemicals and incidence of neuroblastoma in offspring | Q74179923 | ||
| Prognostic impact of P53 status in Ewing sarcoma | Q74199510 | ||
| Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan | Q74245204 | ||
| Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions | Q74340307 | ||
| Immune rejection of a large sarcoma following cyclophosphamide and IL-12 treatment requires both NK and NK T cells and is associated with the induction of a novel NK T cell population | Q74388160 | ||
| Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors | Q74495598 | ||
| Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model | Q74545263 | ||
| 111 renal neoplasms of childhood: a clinicopathologic study | Q74588197 | ||
| Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma | Q74610152 | ||
| Increased serum VEGF in 13 children with Wilms' tumour falls after surgery but rising levels predict poor prognosis | Q74613848 | ||
| [Prune belly syndrome and congenital kidney tumors] | Q77305087 | ||
| Cytogenetic-clinicopathologic correlations in rhabdomyosarcoma: a report of five cases | Q77324195 | ||
| Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor | Q77358795 | ||
| Parental cancer as a risk factor for bone cancer: a nation-wide study from Sweden | Q77541739 | ||
| Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group | Q77614518 | ||
| Ewing sarcoma of the small intestine | Q77729264 | ||
| Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression | Q77733241 | ||
| Perinatal exposure to infection and risk of childhood leukemia | Q78029587 | ||
| Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study | Q95721658 | ||
| Surgical outcomes in osteosarcoma | Q74060115 | ||
| Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor | Q74082526 | ||
| Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response | Q43905376 | ||
| Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells | Q43912438 | ||
| Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues | Q44188999 | ||
| Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results | Q44435059 | ||
| Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group | Q44557261 | ||
| Rosette-forming epithelioid osteosarcoma: a histologic subtype with highly aggressive clinical behavior | Q44657615 | ||
| The role of surgery and resection margins in the treatment of Ewing's sarcoma. | Q44824665 | ||
| Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. | Q45101249 | ||
| Parental occupational exposures to electromagnetic fields and radiation and the incidence of neuroblastoma in offspring | Q45215647 | ||
| Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study | Q45242398 | ||
| Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals | Q45714399 | ||
| Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA. | Q45878766 | ||
| Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression | Q46419102 | ||
| Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group | Q46464273 | ||
| Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study | Q47691706 | ||
| A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor | Q48129277 | ||
| Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality | Q48132856 | ||
| Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors | Q48192128 | ||
| The treatment of malignant scala posterior tumors in children: II. Preliminary result of the pre- and postoperative adjuvant chemotherapy of scala posterior tumors | Q48353540 | ||
| Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications | Q48368986 | ||
| Trends in Reported Incidence of Primary Malignant Brain Tumors in Children in the United States | Q48398308 | ||
| Permeability Characteristics of Brain Adjacent to Tumors in Rats | Q48427529 | ||
| Methylphenidate therapy improves cognition, mood, and function of brain tumor patients | Q48429646 | ||
| High-dose cyclophosphamide for poor-prognosis and recurrent pediatric brain tumors: a dose-escalation study. | Q48616279 | ||
| Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified Phase II trial | Q48709929 | ||
| Intracranial Ewing sarcoma/'peripheral' primitive neuroectodermal tumor of dural origin with molecular genetic confirmation | Q48882456 | ||
| Effect of P-glycoprotein expression on outcome in the Ewing family of tumors. | Q49170001 | ||
| Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study | Q49185724 | ||
| Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro | Q50511070 | ||
| Methotrexate pharmacokinetics and prognosis in osteosarcoma | Q52374633 | ||
| Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood | Q53318349 | ||
| Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results. | Q53319588 | ||
| International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group | Q53319603 | ||
| Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors | Q53324755 | ||
| Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS). | Q53390484 | ||
| Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee | Q53404096 | ||
| Comparative genomic hybridization in ganglioneuroblastomas | Q53922826 | ||
| Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system | Q53985468 | ||
| The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response. | Q53992206 | ||
| Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma | Q54001348 | ||
| Expression of p53 and prognosis in children with malignant gliomas. | Q55473725 | ||
| Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors. | Q55474881 | ||
| Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. | Q55475283 | ||
| Medulloblastoma--challenges in radiation therapy and the addition of chemotherapy. | Q55476192 | ||
| Autoregulation of the interleukin-1 system and cytokine-cytokine interactions in primary human astrocytoma cells. | Q55476210 | ||
| Medulloblastoma: time–dose relationship based on a 30-year review | Q55477493 | ||
| Preoperative chemotherapy with carboplatin alone in high risk medulloblastoma. | Q55480397 | ||
| Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. | Q55481597 | ||
| A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group. | Q55485369 | ||
| Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma. | Q55486184 | ||
| Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases | Q57007859 | ||
| Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial | Q33340568 | ||
| Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group | Q33341085 | ||
| Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide | Q33341259 | ||
| Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors | Q33489081 | ||
| Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group | Q33503725 | ||
| Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. | Q33539849 | ||
| Epidemiologic impact of children with brain tumors | Q33797772 | ||
| Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas | Q33885722 | ||
| Spontaneous remission of congenital leukemia: a case for conservative treatment | Q33948615 | ||
| Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease | Q33951643 | ||
| Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients | Q33953723 | ||
| Trastuzumab in the treatment of metastatic breast cancer : anticancer therapy versus cardiotoxicity | Q33971055 | ||
| Exploitation of immune mechanisms in the treatment of central nervous system cancer | Q33983479 | ||
| What causes childhood brain tumors? Limited knowledge, many clues | Q34022348 | ||
| Soft tissue Ewing sarcoma--peripheral primitive neuroectodermal tumor with atypical clear cell pattern shows a new type of EWS-FEV fusion transcript | Q34025244 | ||
| Chest radiography versus chest CT in the evaluation for pulmonary metastases in patients with Wilms' tumor: a retrospective review | Q34036848 | ||
| Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors | Q34105989 | ||
| Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. | Q34108090 | ||
| Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997. | Q34113333 | ||
| Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, German | Q34121096 | ||
| Primary osteosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 22 cases with a review of the literature | Q34136336 | ||
| Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry | Q34150299 | ||
| Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients | Q34166560 | ||
| Treatment strategies for metastatic Ewing's sarcoma | Q34297795 | ||
| Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death | Q34340920 | ||
| Neuroblastoma tumour genetics: clinical and biological aspects | Q34453849 | ||
| Temporal increases in the incidence of childhood solid tumors seen in Northwest England (1954-1998) are likely to be real | Q34464278 | ||
| Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: Report of five infants | Q34464467 | ||
| Chromosomal regions involved in the pathogenesis of osteosarcomas. | Q34509342 | ||
| Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. | Q34515936 | ||
| Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. | Q34518343 | ||
| The molecular basis of Turcot's syndrome | Q34662365 | ||
| Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditions | Q34749898 | ||
| The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour study | Q36621777 | ||
| A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy | Q36622068 | ||
| Parental cancer as a risk factor for nine common childhood malignancies | Q36622828 | ||
| The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma | Q36623109 | ||
| Neuroblastoma in monozygotic twins--a case of probable twin-to-twin metastasis | Q36623560 | ||
| Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? | Q36643391 | ||
| Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status | Q36691979 | ||
| The co-expression of p53 protein and P-glycoprotein is correlated to a poor prognosis in osteosarcoma | Q36749360 | ||
| Clinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma | Q36751205 | ||
| Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study | Q36773034 | ||
| EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells | Q37362452 | ||
| The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle | Q37395003 | ||
| Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study | Q37871379 | ||
| Clinicopathologic Analysis of HER-2/neu Immunoexpression among Various Histologic Subtypes and Grades of Osteosarcoma | Q38458593 | ||
| Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma | Q38460389 | ||
| Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma | Q38461004 | ||
| Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas | Q38462096 | ||
| Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind Study | Q38557135 | ||
| Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy | Q39511369 | ||
| Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. | Q39528189 | ||
| Long-term sequelae of cancer treatment on the central nervous system in childhood | Q39670799 | ||
| Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study | Q40661469 | ||
| Controlled pilot study of piracetam for pediatric opsoclonus-myoclonus | Q40665404 | ||
| Activation of trkA induces differentiation and inhibits the growth of JK-GMS Askin tumor cells | Q40750316 | ||
| Soluble factors, including TNF alpha, secreted by human T cells are both cytotoxic and cytostatic for medulloblastoma cells | Q40921535 | ||
| Expression of TRAIL and its receptors in human brain tumors | Q40961600 | ||
| Replicative senescence: an old lives' tale? | Q40968415 | ||
| Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. | Q40975748 | ||
| Gene fusions encoding chimaeric transcription factors in solid tumours | Q41025087 | ||
| An overview of the clinical and molecular genetics of Wilms' tumor | Q41127702 | ||
| Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. | Q41739913 | ||
| Epidemiological evidence for an infective basis in childhood leukaemia | Q42590345 | ||
| Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop | Q42639892 | ||
| Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial | Q43514175 | ||
| Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. | Q43543641 | ||
| Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study | Q43607779 | ||
| Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma | Q43623316 | ||
| High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. | Q43626751 | ||
| Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group | Q43648912 | ||
| High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma | Q43661037 | ||
| Neoadjuvant chemotherapy for patients with synchronous multifocal osteosarcoma: results in eleven cases | Q43672088 | ||
| N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. | Q43682587 | ||
| Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial | Q43742466 | ||
| Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study | Q43826506 | ||
| Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma. | Q43831224 | ||
| Acquisition of secondary structural chromosomal changes in pediatric ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome | Q57791000 | ||
| Genetic Alterations in Childhood Medulloblastoma Analyzed by Comparative Genomic Hybridization | Q58183532 | ||
| Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours | Q58197486 | ||
| Survival of children with Wilms' tumour in Europe | Q58218221 | ||
| Survival of children with soft-tissue sarcoma in Europe since 1978 | Q58218223 | ||
| Analysis of the p53 gene by PCR-SSCP in ten cases of Wilms’ tumor | Q58855563 | ||
| FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy | Q59401690 | ||
| Paratesticular Rhabdomyosarcoma: Report From the Italian and German Cooperative Group | Q63185701 | ||
| Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study | Q64211472 | ||
| Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study | Q69350980 | ||
| Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy | Q70992219 | ||
| Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome | Q71523309 | ||
| Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial | Q71848701 | ||
| Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma | Q72227223 | ||
| Phase I study of phenylacetate administered twice daily to patients with cancer | Q72295048 | ||
| Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer | Q72684562 | ||
| Brain tumors in children | Q72827847 | ||
| Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies | Q72856071 | ||
| Activation of TRK genes in Ewing's sarcoma. Trk A receptor expression linked to neural differentiation | Q73063429 | ||
| SIOP treatment guidelines for renal tumours in small infants: fact or fantasy? | Q73085511 | ||
| Prenatal origin of acute lymphoblastic leukaemia in children | Q73156477 | ||
| Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children | Q73181502 | ||
| Variable presentation of Rothmund-Thomson syndrome | Q73259874 | ||
| Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma | Q73271508 | ||
| Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents | Q73271569 | ||
| Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European Osteosarcoma Intergroup | Q73300375 | ||
| Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's | Q73300396 | ||
| Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma | Q73387389 | ||
| Congenital alveolar rhabdomyosarcoma: clinical and molecular distinction from alveolar rhabdomyosarcoma in older children | Q73421740 | ||
| Telomerase activity as a prognostic factor in neuroblastomas | Q73493341 | ||
| Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor | Q73535794 | ||
| Comparative genomic hybridization analysis of Wilms tumors | Q73668835 | ||
| Prognostic impact of tumor perfusion in MR-imaging studies in Ewing tumors | Q73708890 | ||
| Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours | Q73780146 | ||
| Survival of children with neuroblastoma. time trends and regional differences in Europe, 1978--1992 | Q73780501 | ||
| Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group | Q73794136 | ||
| Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience | Q73798185 | ||
| Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors | Q73853983 | ||
| Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma | Q73853986 | ||
| Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV | Q73900855 | ||
| Comparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma | Q73918291 | ||
| Expression of MIB and BCL-2 in patients with nephrogenic rests with and without associated Wilms' tumors | Q73922907 | ||
| Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma | Q73940408 | ||
| Detection of c-fos expression in benign and malignant musculoskeletal lesions | Q73998080 | ||
| Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours | Q74012541 | ||
| Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors | Q74020575 | ||
| Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study | Q74026577 | ||
| P304 | page(s) | 683-707 | |
| P577 | publication date | 2003-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Cancer chemotherapy and biological response modifiers | Q27709711 |
| P1476 | title | Biology and therapy of malignant solid tumors in childhood | |
| P478 | volume | 21 |
Search more.